Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Summary by 6ix AI

Valneva SE announced its participation in upcoming investor conferences in the U.S. and Europe, where senior management will present and hold meetings with institutional investors. The conferences include the Portzamparc BNP Paribas Séminaire Biotech & Santé, Guggenheim Annual Healthcare Innovation Conference, Stifel Healthcare Conference, and Jefferies London Healthcare Conference. Valneva will discuss key value drivers and the regulatory outlook for its Lyme disease vaccine candidate, which is partnered with Pfizer. The company aims to highlight its R&D pipeline and potential future value creation from the Lyme vaccine candidate's approval and commercialization.

Written by 6ix AI from the company’s filing. How 6ix writes summaries